President Trump has decried PhRMA, accusing the drug companies of “getting away with murder,” but so far Congress has taken only baby steps to the problem of surging drug costs, passing a provision from Rep. Kurt Schrader to ease the approval of generic competition to so-called “orphan drugs.”
Oct 17, 2017